贵州三力：海南悦欣医药投资持股比例已降至5.00%

Core Viewpoint - Hainan Yuexin Pharmaceutical Investment Partnership plans to reduce its stake in Guizhou Sanli by selling 509,900 shares, representing 0.12% of the company's total equity [1] Summary by Relevant Sections - Shareholding Changes - After the reduction, Hainan Yuexin will hold 20,490,100 shares, which is 5.00% of Guizhou Sanli's total equity [1] - The share reduction is scheduled to occur between September 24 and September 25, 2025 [1] - Future Intentions - Hainan Yuexin does not rule out the possibility of further reducing its stake in Guizhou Sanli within the next 12 months [1] - The company has committed to fulfilling its information disclosure obligations in accordance with relevant laws and regulations [1]